Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016.

Abstract

OBJECTIVES:

Successful treatment of delirium depends on the detection of the reversible contributors. Drugs with delirogenic properties are the most prevalent reversible cause of delirium.

METHODS:

This observational study is based on data from Arzneimittelsicherheit in der Psychiatrie, a multicenter drug surveillance program in German-speaking countries recording severe adverse drug reactions (ADRs) in psychiatric inpatients. The present study analyzes drug-induced delirium (DID) during treatment with antidepressants and antipsychotics.

RESULTS:

A total of 436 565 psychiatric inpatients were treated with antidepressants and/or antipsychotics during the observation period from 1993 to 2016 in the participating 110 hospitals. Overall, 254 cases (0.06% of all patients treated with antidepressants and/or antipsychotics) of DID were detected. Implicated either in combination or alone (multiple drugs were implicated in 70.1% of DID), clomipramine (0.24%), amitriptyline (0.21%), and clozapine (0.18%) showed the highest incidence rates of DID. When implicated alone (98 cases overall), clozapine (0.11%) followed by amitriptyline (0.05%) were most likely causally associated with the occurrence of DID. Drugs with strong antimuscarinic properties generally exhibited higher risk of DID.

CONCLUSIONS:

With an incidence rate of <0.1%, the use of antidepressants and antipsychotics was rarely associated with DID within the Arzneimittelsicherheit in der Psychiatrie program. Tricyclic antidepressants and clozapine were the most commonly implicated psychotropic drugs. These data support the specific role of antimuscarinic properties in DID.

• Authors: M E Friedrich, R Grohmann, U Rabl, D Winkler, A Konstantinidis, R Engel, J Seifert, S Toto, S Stübner, R Frey, S Kasper
• Journal: The international journal of neuropsychopharmacology (Int J Neuropsychopharmacol) Vol. 25 Issue 7 Pg. 556-566 (08 04 2022) ISSN: 1469-5111 [Electronic] England
• PMID: 35106566 (Publication Type: Journal Article, Multicenter Study, Observational Study)
• Copyright: © The Author(s) 2022. Published by Oxford University Press on behalf of CINP.

Chemical References

• Antidepressive Agents
• Antipsychotic Agents
• Muscarinic Antagonists
• Amitriptyline
• Clozapine

Topics

• Adverse Drug Reaction Reporting Systems
• Amitriptyline
• Antidepressive Agents (adverse effects)
• Antipsychotic Agents (adverse effects)
• Clozapine
• Delirium (chemically induced, drug therapy, epidemiology)
• Humans
• Incidence
• Muscarinic Antagonists
• Psychoses, Substance-Induced